当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析 - 利润表

海尔生物

(688139)

  

流通市值:89.69亿  总市值:89.69亿
流通股本:3.18亿   总股本:3.18亿

利润表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、营业总收入2,280,896,019.231,826,339,651.431,270,455,870.9686,668,622.18
营业收入2,280,896,019.231,826,339,651.431,270,455,870.9686,668,622.18
二、营业总成本1,966,937,346.461,528,552,037.641,034,950,299.72557,268,271.77
营业成本1,125,977,841.74897,464,793.55613,796,745.2336,351,587.42
税金及附加20,814,451.6715,618,579.0911,684,386.055,968,665.04
销售费用339,573,972.29251,803,065168,807,126.280,360,225.34
管理费用183,467,514.04135,906,685.3393,716,330.7445,572,426.09
研发费用320,636,061.79242,651,271.93157,574,507.0980,011,141.6
财务费用-23,532,495.07-14,892,357.26-10,628,795.569,004,226.28
其中:利息费用3,511,618.342,845,834.971,877,762.2888,122.9
其中:利息收入35,609,318.8323,938,719.4614,578,931.766,774,013.3
加:公允价值变动收益2,055,633.22-4,125,990.781,459,949.22319,226.22
加:投资收益83,033,401.6373,352,937.3858,134,146.0113,015,767.85
资产处置收益-1,599,128.48-2,062,769.54-2,062,769.54-
资产减值损失(新)-1,642,752.84-1,459,756.76-1,520,953.03545,754.01
信用减值损失(新)-2,418,299.47-993,675.42-431,240.0947,880.39
其他收益45,013,812.5632,681,352.7120,940,129.358,013,605.59
营业利润平衡项目0000
四、营业利润438,401,339.39395,179,711.38312,024,833.1151,342,584.47
加:营业外收入3,341,881.012,512,599.461,309,461677,842.13
减:营业外支出7,252,010.976,069,846.676,069,189.7926,898.42
利润总额平衡项目0000
五、利润总额434,491,209.43391,622,464.17307,265,104.31151,993,528.18
减:所得税费用22,432,550.6725,976,61923,053,475.2712,483,714.67
六、净利润412,058,658.76365,645,845.17284,211,629.04139,509,813.51
持续经营净利润412,058,658.76365,645,845.17284,211,629.04139,509,813.51
归属于母公司股东的净利润406,073,643.93357,201,281.16278,462,841.61137,535,031.82
少数股东损益5,985,014.838,444,564.015,748,787.431,974,781.69
(一)基本每股收益1.281.130.880.43
(二)稀释每股收益1.281.130.880.43
八、其他综合收益-43,521,492.11-30,515,814.23-29,978,428.7398,055.44
归属于母公司股东的其他综合收益-43,521,492.11-30,515,814.23-29,978,428.7398,055.44
九、综合收益总额368,537,166.65335,130,030.94254,233,200.31139,607,868.95
归属于母公司股东的综合收益总额362,552,151.82326,685,466.93248,484,412.88137,633,087.26
归属于少数股东的综合收益总额5,985,014.838,444,564.015,748,787.431,974,781.69
公告日期2024-03-282023-10-272023-08-302023-04-26
审计意见(境内)标准无保留意见
TOP↑